GVAX

DB17276InvestigationalVaccines

GVAX is a granulocyte-macrophage colony-stimulating factor (GM-CSF) gene-transfected tumor cell vaccine.

Also known as
GVAX Pancreatic Cancer Vaccine

What you can answer from here — as of March 31, 2026

4Clinical trialsPhase, status and sponsor resolved per trial
Sign in

Which companies are running trials of GVAX, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In